✦ LIBER ✦

Nasal Delivery of Antimigraine Drugs: Clinical Rationale and Evidence Base

✍ Scribed by Alan Rapoport; Paul Winner

Book ID: 109099773
Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 103 KB
Volume: 46
Category: Article
ISSN: 0017-8748
DOI: 10.1111/j.1526-4610.2006.00603.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

In-vitro nasal drug delivery studies: co

In-vitro nasal drug delivery studies: comparison of derivatised, fibrillar and polymerised collagen matrix-based human nasal primary culture systems for nasal drug delivery studies

✍ Remigius Uchenna Agu; Mark Jorissen; Tom Willems; Patrick Augustijns; Renaat Kin 📂 Article 📅 2001 🏛 Pharmaceutical Press 🌐 English ⚖ 384 KB

PET imaging-based evaluation of aerosol

PET imaging-based evaluation of aerosol drugs and their delivery devices: nasal and pulmonary studies

✍ Zhenghong Lee, ; Berridge, M.S. 📂 Article 📅 2002 🏛 IEEE 🌐 English ⚖ 431 KB

Scintigraphic evaluation in rabbits of n

Scintigraphic evaluation in rabbits of nasal drug delivery systems based on carbopol 971p® and carboxymethylcellulose

✍ Michael Ikechukwu Ugwoke; Remigius Uchenna Agu; Hubert Vanbilloen; Jan Baetens; 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 194 KB

Drug delivery trends in clinical trials

Drug delivery trends in clinical trials and translational medicine: Challenges and opportunities in the delivery of nucleic acid-based therapeutics

✍ Long Xu; Thomas Anchordoquy 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 162 KB 👁 1 views

The ability to deliver nucleic acids (e.g., plasmid DNA, antisense oligonucleotides, siRNA) offers the potential to develop potent vaccines and novel therapeutics. However, nucleic acid-based therapeutics are still in their early stages as a new category of biologics. The efficacy of nucleic acids r

Rationale and design of a randomized tri

Rationale and design of a randomized trial to evaluate an evidence-based prescription drug label on actual medication use

✍ William H. Shrank; Ruth Parker; Terry Davis; Anjali U. Pandit; JoAnn P. Knox; Pe 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 605 KB

An evidence-based assessment of the clin

An evidence-based assessment of the clinical significance of drug-drug interactions between disease-modifying antirheumatic drugs and non-antirheumatic drugs according to rheumatologists and pharmacists

✍ Eric N. van Roon; Patricia M.L.A. van den Bemt; Tim L.Th.A. Jansen; Nella M. Hou 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 145 KB